Unknown NA INTERVENTIONAL 2-arm NCT03038490

The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure Ulcers

The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for the Treatment of Pressure Ulcers

Sponsor: Our Lady of Maryknoll Hospital

Conditions Pressure Ulcer, Stage IV Pressure Ulcers Stage III

Interventions ABOUND

Updated 6 times since 2017 Last updated: Jan 30, 2017 Started: Dec 1, 2016 Primary completion: Sep 30, 2019 Completion: Mar 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Pressure Ulcer, Stage IV and Pressure Ulcers Stage III and is currently ongoing. Our Lady of Maryknoll Hospital leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
May 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — May 2020 [monthly]

Recruiting NA

▶ Show 1 earlier version

Feb 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Our Lady of Maryknoll Hospital
Wong Tai Sin Hospital

Data source: Our Lady of Maryknoll Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wong Tai Sin, Hong Kong